Sanofi Consumer Healthcare expects to find out before the end of the quarter whether its program to switch erectile dysfunction drug Cialis in the US can get back underway after a long delay.
Sanofi Awaiting Key Meeting With FDA To Recommence Cialis Switch
Sanofi is waiting to hear from FDA whether it has done enough to recommence its Cialis actual-use trial, which has been on hold for almost two years. The France-based firm gave an update on the Cialis switch program as it reported higher Consumer Healthcare sales in Q4.